Polycystic ovary syndrome with hyperandrogenism as a risk factor for non‐obese non‐alcoholic fatty liver disease
Alimentary Pharmacology & Therapeutics2017Vol. 45(11), pp. 1403–1412
Citations Over TimeTop 10% of 2017 papers
J. J. Kim, Donghee Kim, Jeong Yoon Yim, Joohyun Kang, Kyuhee Han, Sun Moon Kim, Kyu Ri Hwang, Seung‐Yup Ku, Chang Suk Suh, Sang Hoon Kim, Young Min Choi
Abstract
Non-obese NAFLD is more prevalent in women with polycystic ovary syndrome than in those without. In non-obese patients with polycystic ovary syndrome, hyperandrogenemia may be an independent risk factor for non-obese NAFLD.
Related Papers
- → Current aspects of polycystic ovary syndrome: A literature review(2016)70 cited
- → Clinical expression of polycystic ovary syndrome in adolescent girls(2006)92 cited
- Polycystic ovary syndrome and acne.(2011)
- → Phenotypic Variation of Polycystic Ovary Syndrome(2007)5 cited
- → NORMOANDROGENIC VERSUS HYPERANDROGENIC WOMEN WITH POLYCYSTIC OVARY SYNDROME AND THEIR METABOLIC AND CARDIOVASCULAR PROFILE LATER IN LIFE(2021)